Positive nod from FDA for Gilead's Maryland site
Gilead targets 400 jobs, assembles cell therapy manufacturing troika with FDA nod for Maryland site.
Gilead | 23/04/2022 | By Sudeep Soparkar | 590
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy